Cargando…

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone

The global spread of Zika virus (ZIKV) and its unexpected association with congenital defects necessitates the rapid development of a safe and effective vaccine. Here we report the development and characterization of a recombinant chimeric ZIKV vaccine candidate (termed ChinZIKV) that expresses the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Feng, Dong, Hao-Long, Wang, Hong-Jiang, Huang, Xing-Yao, Qiu, Ye-Feng, Ji, Xue, Ye, Qing, Li, Chunfeng, Liu, Yang, Deng, Yong-Qiang, Jiang, Tao, Cheng, Gong, Zhang, Fu-Chun, Davidson, Andrew D., Song, Ya-Jun, Shi, Pei-Yong, Qin, Cheng-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813210/ https://www.ncbi.nlm.nih.gov/pubmed/29445153 http://dx.doi.org/10.1038/s41467-018-02975-w

Ejemplares similares

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
por: Chen, Qi, et al.
Publicado: (2018)

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
por: Touret, Franck, et al.
Publicado: (2018)

A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Chin, Wei-Xin, et al.
Publicado: (2021)

Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Chen, Qi, et al.
Publicado: (2019)

Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
por: Harrison, Jessica J., et al.
Publicado: (2021)

Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
por: Taslem Mourosi, Jarin, et al.
Publicado: (2022)

2138. Evaluating the Safety and Immunogenicity of the rZIKV/D4Δ30-713 Live Attenuated Chimeric Zika Candidate Vaccine in Healthy Flavivirus-Naïve Adults
por: Zhong, Diana, et al.
Publicado: (2022)

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
por: Giel-Moloney, Maryann, et al.
Publicado: (2018)

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis
por: Xie, Xuping, et al.
Publicado: (2017)

Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans
por: Malafa, Stefan, et al.
Publicado: (2020)

Viral RNA switch mediates the dynamic control of flavivirus replicase recruitment by genome cyclization
por: Liu, Zhong-Yu, et al.
Publicado: (2016)

Memory T Cells in Flavivirus Vaccination
por: Li, Guangyu, et al.
Publicado: (2018)

Protective Efficacy of a Chimeric Insect-Specific Flavivirus Vaccine against West Nile Virus
por: Vet, Laura J., et al.
Publicado: (2020)

The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge
por: Hazlewood, Jessamine E., et al.
Publicado: (2022)

Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism
por: Wang, Hong-Jiang, et al.
Publicado: (2022)

Zika, Flavivirus and Malaria Antibody Cocirculation in Nigeria
por: Mac, Peter Asaga, et al.
Publicado: (2023)

The Interface between Methyltransferase and Polymerase of NS5 Is Essential for Flavivirus Replication
por: Li, Xiao-Dan, et al.
Publicado: (2014)

Structural Basis of Zika Virus Specific Neutralization in Subsequent Flavivirus Infections
por: Sevvana, Madhumati, et al.
Publicado: (2020)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Production of a chimeric flavivirus that contains the major structural glycoprotein genes of T’Ho virus in the genetic background of Zika virus
por: Tangudu, Chandra S., et al.
Publicado: (2023)

Perspectives for licensing vaccines in Mexico
por: Padron-Regalado, Eriko, et al.
Publicado: (2022)

Bioinformatics in New Generation Flavivirus Vaccines
por: Koraka, Penelope, et al.
Publicado: (2010)

Flavivirus vaccines: Innovate, invest, implement
Publicado: (2016)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

Capsid protein structure in Zika virus reveals the flavivirus assembly process
por: Tan, Ter Yong, et al.
Publicado: (2020)

The mysterious Zika virus: Adding to the tropical flavivirus mayhem
por: Mishra, B, et al.
Publicado: (2016)

Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity
por: Goh, Gerard Kian-Meng, et al.
Publicado: (2019)

Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone
por: Gao, Jin, et al.
Publicado: (2021)

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity
por: Zou, Jing, et al.
Publicado: (2018)

A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
por: Kum, Dieudonné B., et al.
Publicado: (2018)

Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India
por: Dar, Lalit, et al.
Publicado: (2023)

Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines
por: Collins, Natalie D., et al.
Publicado: (2020)

Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling
por: Li, Xiao-Feng, et al.
Publicado: (2017)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Assembly-defective Tembusu virus ectopically expressing capsid protein is an approach for live-attenuated flavivirus vaccine development
por: He, Yu, et al.
Publicado: (2022)

An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines
por: Hickman, Danielle, et al.
Publicado: (2008)

Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups
por: Bonifacio, João P. P. L., et al.
Publicado: (2022)

Replication/Assembly Defective Avian Flavivirus With Internal Deletions in the Capsid Can Be Used as an Approach for Living Attenuated Vaccine
por: He, Yu, et al.
Publicado: (2021)

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus
por: Baldwin, Whitney R., et al.
Publicado: (2021)

Rational Design of a Live Attenuated Dengue Vaccine: 2′-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques
por: Züst, Roland, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_87iemc8d6h77at0qutldmditbq